Biobank Publications

Cureus Part of Springer Nature Cureus (2022 Oct 25) – The spectrum of erythema migrans in early Lyme disease: Can we improve its recognition?


Frontiers logo Frontiers in Medicine (2021 Aug 18) – Recent progress in Lyme disease and remaining challenges
Journal of Clinical Microbiology (2020 May 26) – The Lyme Disease Biobank: Characterization of 550 patient and control samples from the East Coast and Upper Midwest of the United States


Published Studies Using Lyme Disease Biobank Samples and Data

eBioMedicine logo eBioMedicine (2024 Jan 23) – Host glycosylation of immunoglobulins impairs the immune response to acute Lyme disease


Frontiers logo

Frontiers in Immunology (2024 Jan 22) – Highly heterogenous humoral immune response in Lyme disease patients revealed by broad machine learning-assisted antibody binding profiling with random peptide arrays

International Journal of General Medicine (2023 Jun 17) – Does biological sex matter in Lyme disease? The need for sex-disaggregated data in persistent illness


Frontiers logo Frontiers in Cellular and Infection Microbiology (2022 Oct 27) – Testing Raman spectroscopy as a diagnostic approach for Lyme disease patients
Frontiers logo Frontiers in Immunology (2022 Aug 5) – Acute lyme disease IgG N-linked glycans contrast the canonical inflammatory signature
Frontiers logo Frontiers in Microbiology (2022 Mar 7) – Capture sequencing enables sensitive detection of tick-borne agents in human blood
Journal of Clinical Microbiology (2021 Jan 21) – Serum epitope repertoire analysis enables early detection of Lyme disease with improved ssensitivity in an expandable multiplex format


Scientific Reports Nature Research logo Scientific Reports Nature Research (2020 Dec 10) – Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry


Computers in Biology and Medicine (2020 Oct) – AI-based detection of erythema migrans and disambiguation against other skin lesions





Plos One (2020 Feb 10) – A fluorescent plasmonic biochip assay for multiplex screening of diagnostic serum antibody targets in human Lyme disease

ACS logo


ACS Nano (2020 Jan 28) – Point-of-care serodiagnostic test for early-stage Lyme disease using a multiplexed paper-based immunoassay and machine learning



Journal of Clinical Microbiology (2019 Nov 22) – A multiplexed serologic test for diagnosis of Lyme disease for point-of-care use